Xenetic Biosciences Inc
XBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.35M
Close$
$7.48
200.6% upside
Current Fair Value
200.6% upsideUndervalued by 200.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.35 Million |
|---|---|
| Enterprise Value | $-125,544.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.58 |
| Beta | 2.24 |
| Outstanding Shares | 2,294,364 |
Return
| Return on Equity | -40.76% |
|---|---|
| Return on Assets | -35.52% |
| Return on Invested Capital | -42.92% |
Valuation & Multiples
| P/E Ratio | -2.33 |
|---|---|
| PEG | -6.65 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | -0.04 |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xenetic Biosciences Inc
2,018 employees